Drugs / Sulfadiazine
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | SULFADIAZINE | — | 1941-08-11 | fda.gov ↗ |
Trials 2 · a red edge is where a trial was stopped
194019411942194319441945194619471948194919501951195219531954195519561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00000794 | ? → Apr 1998 | HIV infectious disease, cerebral toxoplasmosis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00367081 | May 2003 → Aug 2004 | AIDS, cerebral toxoplasmosis | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02099240 Comparator | Mar 2014 → Nov 2018 | osteomyelitis | University of Louisville | Terminated | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT01189448 Comparator | Nov 2010 → Jul 2014 | congenital toxoplasmosis | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT00372294 Comparator | Jul 2005 → Aug 2008 | chorioretinitis | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00004317 Background | Jul 2000 → Dec 2030 expected | toxoplasmosis | National Institute of Allergy and Infectious Diseases (NIAID) | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulfadiazine | “Sulfadiazine” NCT02099240 ↗ |
| Known as | Sulfadiazine = Adiazine | “Sulfadiazine = Adiazine®” NCT01189448 ↗ |
| Route | Oral | “Sulfadiazine and leucovorin calcium are also given orally for 12 months.” NCT00004317 ↗ |